Second Line Capital, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1992879
METAIRIE, LA
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$558,821
+$27,885 QoQ
Shares Held
1,125
-5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,012
of 1,705 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Second Line Capital, LLC holds $6,830,265 across 2 Biotechnology names. VRTX ranks #2 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OCUL |
Ocular Therapeutix, Inc
|
638,640 | $6,271,444 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,125 | $558,821 |
All Filings in VRTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $558,821 | 1,125 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $530,936 | 1,189 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $518,643 | 1,144 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $436,678 | 1,115 | Shares | Sole | 2025-11-19 | |
| No filing history on record for this holder in this stock. | ||||||